177 related articles for article (PubMed ID: 31738648)
1. The association of cognitive performance and IL-6 levels in schizophrenia is influenced by age and antipsychotic treatment.
Ribeiro-Santos R; de Campos-Carli SM; Ferretjans R; Teixeira-Carvalho A; Martins-Filho OA; Teixeira AL; Salgado JV
Nord J Psychiatry; 2020 Apr; 74(3):187-193. PubMed ID: 31738648
[No Abstract] [Full Text] [Related]
2. Decreased serum TNF-alpha levels in chronic schizophrenia patients on long-term antipsychotics: correlation with psychopathology and cognition.
Lv MH; Tan YL; Yan SX; Tian L; Chen DC; Tan SP; Wang ZR; Yang FD; Yoon JH; Zunta-Soares GB; Soares JC; Zhang XY
Psychopharmacology (Berl); 2015 Jan; 232(1):165-72. PubMed ID: 24958229
[TBL] [Abstract][Full Text] [Related]
3. Interaction of BDNF with cytokines in chronic schizophrenia.
Zhang XY; Tan YL; Chen DC; Tan SP; Yang FD; Wu HE; Zunta-Soares GB; Huang XF; Kosten TR; Soares JC
Brain Behav Immun; 2016 Jan; 51():169-175. PubMed ID: 26407757
[TBL] [Abstract][Full Text] [Related]
4. The effect of minocycline on amelioration of cognitive deficits and pro-inflammatory cytokines levels in patients with schizophrenia.
Zhang L; Zheng H; Wu R; Kosten TR; Zhang XY; Zhao J
Schizophr Res; 2019 Oct; 212():92-98. PubMed ID: 31416745
[TBL] [Abstract][Full Text] [Related]
5. Serum IL-1beta, sIL-2R, IL-6, IL-8 and TNF-alpha in schizophrenic patients, relation with symptomatology and responsiveness to risperidone treatment.
Erbağci AB; Herken H; Köylüoglu O; Yilmaz N; Tarakçioglu M
Mediators Inflamm; 2001 Jun; 10(3):109-15. PubMed ID: 11545247
[TBL] [Abstract][Full Text] [Related]
6. Increased Levels of Plasma Tumor Necrosis Factor-α Mediate Schizophrenia Symptom Dimensions and Neurocognitive Impairments and Are Inversely Associated with Natural IgM Directed to Malondialdehyde and Paraoxonase 1 Activity.
Maes M; Sirivichayakul S; Matsumoto AK; Maes A; Michelin AP; de Oliveira Semeão L; de Lima Pedrão JV; Moreira EG; Barbosa DS; Geffard M; Carvalho AF; Kanchanatawan B
Mol Neurobiol; 2020 May; 57(5):2333-2345. PubMed ID: 32040834
[TBL] [Abstract][Full Text] [Related]
7. Meta-analysis of cytokine alterations in schizophrenia: clinical status and antipsychotic effects.
Miller BJ; Buckley P; Seabolt W; Mellor A; Kirkpatrick B
Biol Psychiatry; 2011 Oct; 70(7):663-71. PubMed ID: 21641581
[TBL] [Abstract][Full Text] [Related]
8. Increased interleukin-2 serum levels were associated with psychopathological symptoms and cognitive deficits in treatment-resistant schizophrenia.
Tan Y; Li Y; Tan S; Wang Z; Yang FD; Cao B; Zunta-Soares GB; Soares JC; Zhang XY
Schizophr Res; 2015 Dec; 169(1-3):16-21. PubMed ID: 26549630
[TBL] [Abstract][Full Text] [Related]
9. [Analysis of the changes of serum high mobility group protein B1 and cytokines in first-episode schizophrenia patients].
Zhu Q; Li X; Hie G; Yuan X; Lü L; Song X
Zhonghua Yi Xue Za Zhi; 2015 Dec; 95(47):3818-22. PubMed ID: 27337797
[TBL] [Abstract][Full Text] [Related]
10. Serum levels of interleukin-6 and tumor necrosis factor-alpha in exacerbation and remission phase of schizophrenia.
Dunjic-Kostic B; Jasovic-Gasic M; Ivkovic M; Radonjic NV; Pantovic M; Damjanovic A; Poznanovic ST; Jovanovic A; Nikolic T; Petronijevic ND
Psychiatr Danub; 2013 Mar; 25(1):55-61. PubMed ID: 23470607
[TBL] [Abstract][Full Text] [Related]
11. Antipsychotic treatment may alter T-helper (TH) 2 arm cytokines.
Pae CU; Yoon CH; Kim TS; Kim JJ; Park SH; Lee CU; Lee SJ; Lee C; Paik IH
Int Immunopharmacol; 2006 Apr; 6(4):666-71. PubMed ID: 16504930
[TBL] [Abstract][Full Text] [Related]
12. Relationships between serum brain-derived neurotrophic factor, plasma catecholamine metabolites, cytokines, cognitive function and clinical symptoms in Japanese patients with chronic schizophrenia treated with atypical antipsychotic monotherapy.
Hori H; Yoshimura R; Katsuki A; Atake K; Igata R; Konishi Y; Nakamura J
World J Biol Psychiatry; 2017 Aug; 18(5):401-408. PubMed ID: 27409727
[TBL] [Abstract][Full Text] [Related]
13. Plasma levels of matrix metalloproteinase-9 (MMP-9) are associated with cognitive performance in patients with schizophrenia.
Kudo N; Yamamori H; Ishima T; Nemoto K; Yasuda Y; Fujimoto M; Azechi H; Niitsu T; Numata S; Ikeda M; Iyo M; Ohmori T; Fukunaga M; Watanabe Y; Hashimoto K; Hashimoto R
Neuropsychopharmacol Rep; 2020 Jun; 40(2):150-156. PubMed ID: 32022478
[TBL] [Abstract][Full Text] [Related]
14. Lifetime antipsychotic medication and cognitive performance in schizophrenia at age 43 years in a general population birth cohort.
Husa AP; Moilanen J; Murray GK; Marttila R; Haapea M; Rannikko I; Barnett JH; Jones PB; Isohanni M; Remes AM; Koponen H; Miettunen J; Jääskeläinen E
Psychiatry Res; 2017 Jan; 247():130-138. PubMed ID: 27888683
[TBL] [Abstract][Full Text] [Related]
15. Increased interleukin-6 and tumor necrosis factor alpha in first episode schizophrenia patients versus healthy controls.
Kubistova A; Horacek J; Novak T
Psychiatr Danub; 2012 Sep; 24 Suppl 1():S153-6. PubMed ID: 22945211
[TBL] [Abstract][Full Text] [Related]
16. Minocycline adjunctive treatment to risperidone for negative symptoms in schizophrenia: Association with pro-inflammatory cytokine levels.
Zhang L; Zheng H; Wu R; Zhu F; Kosten TR; Zhang XY; Zhao J
Prog Neuropsychopharmacol Biol Psychiatry; 2018 Jul; 85():69-76. PubMed ID: 29678772
[TBL] [Abstract][Full Text] [Related]
17. Alteration of Serum Levels of Cytokines in Schizophrenic Patients before and after Treatment with Risperidone.
Azizi E; Zavaran Hosseini A; Soudi S; Noorbala AA
Iran J Allergy Asthma Immunol; 2019 Jun; 18(3):262-268. PubMed ID: 31522433
[TBL] [Abstract][Full Text] [Related]
18. Lower serum cytokine levels in smokers than nonsmokers with chronic schizophrenia on long-term treatment with antipsychotics.
Zhang XY; Cao LY; Song C; Wu GY; Chen DC; Qi LY; Wang F; Xiu MH; Chen S; Zhang Y; Lu L; Kosten TA; Kosten TR
Psychopharmacology (Berl); 2008 Dec; 201(3):383-9. PubMed ID: 18719893
[TBL] [Abstract][Full Text] [Related]
19. Serum levels of interleukin-33 and its soluble form receptor (sST2) are associated with cognitive performance in patients with schizophrenia.
de Campos-Carli SM; Miranda AS; Dias IC; de Oliveira A; Cruz BF; Vieira ÉL; Rocha NP; Barbosa IG; Salgado JV; Teixeira AL
Compr Psychiatry; 2017 Apr; 74():96-101. PubMed ID: 28126482
[TBL] [Abstract][Full Text] [Related]
20. Impact of antipsychotic medication on IL-6/STAT3 signaling axis in peripheral blood mononuclear cells of drug-naive schizophrenia patients.
Subbanna M; Shivakumar V; Venugopal D; Narayanaswamy JC; Berk M; Varambally S; Venkatasubramanian G; Debnath M
Psychiatry Clin Neurosci; 2020 Jan; 74(1):64-69. PubMed ID: 31587436
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
